About Metabolomic Diagnostics
Metabolomic Diagnostics is a company based in Cork (Ireland) founded in 2011. Metabolomic Diagnostics has raised $3.89 million across 7 funding rounds from investors including Enterprise Ireland, European Union and EIC Fund. Metabolomic Diagnostics offers products and services including Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions. Metabolomic Diagnostics operates in a competitive market with competitors including Celmatix, adyn, LIA Diagnostics, Confer Health and Milu Labs, among others.
- Headquarter Cork, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.89 M (USD)
in 7 rounds
-
Latest Funding Round
$60.68 K (USD), Grant
Jan 31, 2021
-
Investors
Enterprise Ireland
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Metabolomic Diagnostics
Metabolomic Diagnostics offers a comprehensive portfolio of products and services, including Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions.
System for identifying and translating biomarkers into clinical assays
Tools for multiplexing biomarkers in disease diagnostics
People of Metabolomic Diagnostics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Metabolomic Diagnostics
Metabolomic Diagnostics has successfully raised a total of $3.89M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $60.68 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Metabolomic Diagnostics
Metabolomic Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Metabolomic Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Metabolomic Diagnostics
Investment portfolio details for Metabolomic Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Metabolomic Diagnostics
Detailed financials for Metabolomic Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metabolomic Diagnostics Comparisons
Peer comparison for Metabolomic Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Metabolomic Diagnostics
Metabolomic Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, adyn, LIA Diagnostics, Confer Health and Milu Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fertility decisions are optimized using data analytics and genomics.
|
|
| Locked | Locked | Locked |
Provider of DNA and hormone analysis based birth control optimization kits
|
|
| Locked | Locked | Locked |
Disposable paper pregnancy test kits
|
|
| Locked | Locked | Locked |
Clinical-grade diagnostic tests for home use are developed.
|
|
| Locked | Locked | Locked |
Exosome-based diagnostic products for health screening are offered.
|
Detailed competitors of Metabolomic Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metabolomic Diagnostics
Complete news archive for Metabolomic Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metabolomic Diagnostics
Metabolomic Diagnostics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Metabolomic Diagnostics is headquartered in Cork, Ireland.
Metabolomic Diagnostics is a funded company, having raised a total of $3.89M across 7 funding rounds to date.
Metabolomic Diagnostics was founded in 2011 in Cork, Ireland, where diagnostics and prognostics for maternal health are developed through metabolic profiling. Focus is placed on an early pregnancy test that identifies pre-eclampsia risk by analyzing panels of implicated metabolites. Operations include a subsidiary, Inform Bioscience, within the healthcare diagnostics sector.
Metabolomic Diagnostics's top competitors include Celmatix, LIA Diagnostics and adyn.
Metabolomic Diagnostics offers Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions.
Metabolomic Diagnostics has 6 investors. Key investors include Enterprise Ireland, European Union, EIC Fund, SOSV, and AIB Seed Capital Fund.